BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38177227)

  • 1. The contributions of deleterious rare alleles in NLRP12 and inflammasome-related genes to polymyalgia rheumatica.
    Higuchi T; Oka S; Furukawa H; Tohma S
    Sci Rep; 2024 Jan; 14(1):490. PubMed ID: 38177227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin releasing hormone promoter polymorphisms in giant cell arteritis and polymyalgia rheumatica.
    Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Amoli MM; Thomson W; Ollier WE
    Clin Exp Rheumatol; 2002; 20(2):133-8. PubMed ID: 12051390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis.
    Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Mattey DL; Amoli MM; Thomson W; Ollier WE
    Clin Exp Rheumatol; 2002; 20(2):179-84. PubMed ID: 12051396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
    Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
    J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis.
    Martínez-Taboda VM; Bartolome MJ; Lopez-Hoyos M; Blanco R; Mata C; Calvo J; Corrales A; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2004 Aug; 34(1):454-64. PubMed ID: 15305244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population.
    Combe B; Sany J; Le Quellec A; Clot J; Eliaou JF
    J Rheumatol; 1998 Jan; 25(1):94-8. PubMed ID: 9458210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica.
    Guerne PA; Salvi M; Seitz M; Bruhlmann P; Rivier G; Frey D; Mermillod B; Vischer TL; Tiercy JM
    J Rheumatol; 1997 Apr; 24(4):671-6. PubMed ID: 9101500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.
    Mattey DL; Hajeer AH; Dababneh A; Thomson W; González-Gay MA; García-Porrúa C; Ollier WE
    Arthritis Rheum; 2000 Aug; 43(8):1749-55. PubMed ID: 10943865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.
    Weyand CM; Hunder NN; Hicok KC; Hunder GG; Goronzy JJ
    Arthritis Rheum; 1994 Apr; 37(4):514-20. PubMed ID: 8147928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leucocyte antigens and Japanese patients with polymyalgia rheumatica: the protective effect of
    Nogi S; Oka S; Higuchi T; Furukawa H; Shimada K; Azuma T; Sugiyama T; Hirano F; Okamoto A; Fujimori M; Horai Y; Ihata A; Hashimoto A; Komiya A; Matsui T; Fukui N; Katayama M; Migita K; Tohma S
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38253597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in clinical manifestations and prognosis of Chinese giant cell arteritis patients with or without polymyalgia rheumatica.
    Zhang Y; Wang D; Chu X; Zhang W; Zeng X
    Ir J Med Sci; 2019 May; 188(2):713-720. PubMed ID: 30251177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica.
    Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Amoli MM; Llorca J; Ollier WE
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S18-20. PubMed ID: 15675129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis.
    Makki RF; al Sharif F; González-Gay MA; García-Porrúa C; Ollier WE; Hajeer AH
    Clin Exp Rheumatol; 2000; 18(3):391-3. PubMed ID: 10895380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannose-binding lectin variant alleles and HLA-DR4 alleles are associated with giant cell arteritis.
    Jacobsen S; Baslund B; Madsen HO; Tvede N; Svejgaard A; Garred P
    J Rheumatol; 2002 Oct; 29(10):2148-53. PubMed ID: 12375325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families.
    Liozon E; Ouattara B; Rhaiem K; Ly K; Bezanahary H; Loustaud V; Letellier P; Drouet M; Vidal E
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S89-94. PubMed ID: 19646354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DRB1 alleles in polymyalgia rheumatica and rheumatoid arthritis in southern France.
    Reviron D; Foutrier C; Guis S; Mercier P; Roudier J
    Eur J Immunogenet; 2001 Feb; 28(1):83-7. PubMed ID: 11251689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.
    González-Gay MA; Amoli MM; Garcia-Porrua C; Ollier WE
    Semin Arthritis Rheum; 2003 Aug; 33(1):38-48. PubMed ID: 12920695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polymyalgia rheumatica. Clinical histological study of 46 cases].
    Gerber N; Vernon-Roberts B
    Z Rheumatol; 1977; 36(9-10):275-84. PubMed ID: 930423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.